The U.S. Food and Drug Administration took a good look at the safety and effectiveness of CBD products on Friday, as it weighs how to best regulate the hemp-derived compound going forward.
During a public hearing that stretched for hours, the agency heard testimony from folks on all sides of the issue.
In opening the hearing, FDA Acting Commissioner Dr. Ned Sharpless said, “critical questions remain about the safety” of the products, CNN reported.
“While we have seen an explosion of interest in products containing CBD, there is still